Anti-Human ANGPT2 & VEGFA Recombinant Antibody(Vanucizumab)
-
产品编号
YR1341
-
别名
科研级 Vanucizumab ( 伐努赛珠单抗 ), Anti-ANGPT2 & VEGFA Recombinant Antibody, Research Grade Vanucizumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Vanucizumab ( 伐努赛珠单抗 ), Anti-ANGPT2 & VEGFA Recombinant Antibody, Research Grade Vanucizumab |
Catalog Number | YR1341 |
Molecular Name | Vanucizumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | VH-C Kappa-CH2-CH3_V Lambda-CH1_H-GAMMA-1_L Kappa |
Formulation | PBS, pH7.5 |
Background | Vanucizumab (INN, development code RG7221) is an experimental humanized monoclonal antibody designed for the treatment of cancer. |
CAS Number | 1448221-05-3 |
Application | WB, FCM, IP, ELISA, Neut, FuncS, IF |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | ANGPT2 & VEGFA[Homo sapiens], |